Three-drug therapy may slow deadly skin cancer growth, study says

Source: UPI, July 2019

June 6 (UPI) — Researchers have developed a three-drug combination that may be effective in combating advanced melanoma, a study says.

Their work showed a combination of inhibitor drugs that block a form of melanoma known as BRAF V600E, helpeding to extend the lives of people with the disease, according to the results of two clinical trials publishedThursday in the journal Nature Medicine.

“Utilizing the three drugs together sensitized the patient’s own immune system to bolster the power of immunotherapy and block the growth of two genes – BRAF and MEK – that cause cancer cells to reproduce and grow out of control," Antoni Ribas, a researcher at UCLA and the study’s senior author, said in a news release.